ATE479428T1 - Olanzapin enthaltende pharmazeutische zusammensetzung - Google Patents

Olanzapin enthaltende pharmazeutische zusammensetzung

Info

Publication number: ATE479428T1
Authority: AT; Austria
Prior art keywords: olnzapine; pharmaceutical composition; composition containing; olanzapine; composition
Prior art date: 2005-11-03

Application number

AT06831860T

Other languages

English (en)

Inventor

Torfi Kristjansson

Original Assignee

Actavis Group Ptc Ehf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-03

Filing date

2006-10-27

Publication date

2010-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35516297&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE479428(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-27 Application filed by Actavis Group Ptc Ehf filed Critical Actavis Group Ptc Ehf

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE479428T1 publication Critical patent/ATE479428T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 2
KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 abstract 2
229960005017 olanzapine Drugs 0.000 abstract 2
239000004372 Polyvinyl alcohol Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT06831860T 2005-11-03 2006-10-27 Olanzapin enthaltende pharmazeutische zusammensetzung ATE479428T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0522474.6A GB0522474D0 (en)	2005-11-03	2005-11-03	A pharmaceutical formulation
PCT/IB2006/003922 WO2007052164A2 (en)	2005-11-03	2006-10-27	A pharmaceutical formulation containing olanzapine

Publications (1)

Publication Number	Publication Date
ATE479428T1 true ATE479428T1 (de)	2010-09-15

Family

ID=35516297

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06831860T ATE479428T1 (de)	2005-11-03	2006-10-27	Olanzapin enthaltende pharmazeutische zusammensetzung

Country Status (8)

Country	Link
EP (1)	EP1928428B1 (de)
CN (1)	CN101309673A (de)
AT (1)	ATE479428T1 (de)
CA (1)	CA2626585A1 (de)
DE (1)	DE602006016621D1 (de)
ES (1)	ES2350121T3 (de)
GB (1)	GB0522474D0 (de)
WO (1)	WO2007052164A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2279715B1 (es)	2005-12-26	2008-06-01	Laboratorios Lesvi, S.L.	Formulacion oral de olanzapina.
CL2007002807A1 (es) *	2006-09-29	2008-04-11	Synthon Bv	Composicion farmaceutica en estado solido que comprende olanzapina o una sal farmaceuticamente aceptable de la misma y lactosa anhidra; tableta farmaceutica oral; procedimiento de preparacion de dicha tableta, util en el tratamiento de la esquizofren
CN104208031B (zh) *	2013-07-01	2016-08-31	成都苑东生物制药股份有限公司	一种奥氮平片组合物及其制备方法
EP2774606B1 (de)	2014-02-14	2019-01-30	Synthon B.V.	Pharmazeutische Zusammensetzung mit Ivabradin-Hydrochlorid-Polymorph IV

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine
CR5278A (es)	1995-03-24	1996-07-04	Lilly Co Eli	Formulacion oral de 2-metil-tieno-benzodiacepina
SI21303A (sl) *	2002-10-18	2004-04-30	Krka, Tovarna Zdravil, D.D.,, Novo Mesto	Farmacevtska formulacija olanzapina
AU2003299982B2 (en) *	2002-12-20	2010-04-29	St. James Associates Llc/Faber Research Series	Coated particles for sustained-release pharmaceutical administration
WO2005009407A2 (en) *	2003-07-29	2005-02-03	Ranbaxy Laboratories Limited	Oral pharmaceutical formulations of olanzapine

2005
- 2005-11-03 GB GBGB0522474.6A patent/GB0522474D0/en not_active Ceased
2006
- 2006-10-27 DE DE602006016621T patent/DE602006016621D1/de active Active
- 2006-10-27 CN CNA2006800409483A patent/CN101309673A/zh active Pending
- 2006-10-27 WO PCT/IB2006/003922 patent/WO2007052164A2/en not_active Ceased
- 2006-10-27 ES ES06831860T patent/ES2350121T3/es active Active
- 2006-10-27 CA CA002626585A patent/CA2626585A1/en not_active Abandoned
- 2006-10-27 EP EP06831860A patent/EP1928428B1/de not_active Revoked
- 2006-10-27 AT AT06831860T patent/ATE479428T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB0522474D0 (en)	2005-12-14
DE602006016621D1 (de)	2010-10-14
WO2007052164A2 (en)	2007-05-10
CA2626585A1 (en)	2007-05-10
ES2350121T3 (es)	2011-01-18
WO2007052164A8 (en)	2008-04-17
EP1928428A2 (de)	2008-06-11
EP1928428B1 (de)	2010-09-01
WO2007052164A3 (en)	2007-08-09
CN101309673A (zh)	2008-11-19

Similar Documents

Publication	Publication Date	Title
EA200700201A1 (ru)	2007-08-31	Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
AR062000A1 (es)	2008-08-10	Formulaciones de modificador de respuesta inmune
CR8102A (es)	2006-08-09	Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
BRPI0719395C1 (pt)	2021-05-25	tablete revestido de filme
BRPI0716171A2 (pt)	2013-09-17	composto, composiÇço farmacÊutica e uso de um composto.
ATE374016T1 (de)	2007-10-15	Tablette mit hohem wirkstoffgehalt
CL2007003444A1 (es)	2008-06-27	Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria.
DE60332393D1 (de)	2010-06-10	Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
BRPI0507654A (pt)	2007-07-10	composição farmacêutica compreendendo um derivado de benzodiazepina e um inibidor da proteìna de fusão de rsv
BRPI1009392A2 (pt)	2016-03-08	"formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI0717369A2 (pt)	2014-10-07	Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007001752A1 (es)	2008-01-18	Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
DE602004014765D1 (de)	2008-08-14	Pharmazeutische zusammensetzungen mit atorvastatin, hergestellt ohne granulation
CL2007002619A1 (es)	2008-04-18	Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
EA200901393A1 (ru)	2010-02-26	Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
ATE499939T1 (de)	2011-03-15	Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE415949T1 (de)	2008-12-15	Pharmazeutische formulierung mit levothyroxin- natrium
BRPI0720684A2 (pt)	2016-03-15	composto, medicamento, composição farmacêutica que contém e uso do composto
DE60336999D1 (de)	2011-06-16	Melatonin enthaltende pharmazeutische formulierung
ATE479428T1 (de)	2010-09-15	Olanzapin enthaltende pharmazeutische zusammensetzung
EP1731609A4 (de)	2010-04-07	Rad51-expressionsinhibitor, den inhibitor als wirkstoff enthaltender arzneistoff und nutzung davon
IS2677B (is)	2010-09-15	Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðu hjúpaða með sýrufjölliðu
SV2006002238A (es)	2006-06-26	Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
ATE460934T1 (de)	2010-04-15	Pharmazeutische zubereitungen von ciprofloxacin
TW200640932A (en)	2006-12-01	Clopidogrel base suitable for pharmaceutical formulation and preparation thereof

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties